ATE252600T1 - Ein neuartiger wachstumfaktor und eine genetische sequenz die für diesen kodiert - Google Patents

Ein neuartiger wachstumfaktor und eine genetische sequenz die für diesen kodiert

Info

Publication number
ATE252600T1
ATE252600T1 AT96902810T AT96902810T ATE252600T1 AT E252600 T1 ATE252600 T1 AT E252600T1 AT 96902810 T AT96902810 T AT 96902810T AT 96902810 T AT96902810 T AT 96902810T AT E252600 T1 ATE252600 T1 AT E252600T1
Authority
AT
Austria
Prior art keywords
growth factor
genetic sequence
codes
novel growth
novel
Prior art date
Application number
AT96902810T
Other languages
English (en)
Inventor
Nicholas Kim Hayward
Gunther Weber
Sean Grimmond
Magnus Nordenskjold
Catharina Larsson
Original Assignee
Amrad Operations Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPN1457A external-priority patent/AUPN145795A0/en
Priority claimed from AUPN6647A external-priority patent/AUPN664795A0/en
Priority claimed from AUPN7274A external-priority patent/AUPN727495A0/en
Application filed by Amrad Operations Pty Ltd filed Critical Amrad Operations Pty Ltd
Application granted granted Critical
Publication of ATE252600T1 publication Critical patent/ATE252600T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT96902810T 1995-03-02 1996-02-22 Ein neuartiger wachstumfaktor und eine genetische sequenz die für diesen kodiert ATE252600T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPN1457A AUPN145795A0 (en) 1995-03-02 1995-03-02 A novel growth factor and a genetic sequence encoding same
AUPN6647A AUPN664795A0 (en) 1995-11-20 1995-11-20 A novel growth factor and a genetic sequence encoding same
AUPN7274A AUPN727495A0 (en) 1995-12-22 1995-12-22 A novel growth factor and a genetic sequence encoding same-II
PCT/AU1996/000094 WO1996027007A1 (en) 1995-03-02 1996-02-22 A novel growth factor and a genetic sequence encoding same

Publications (1)

Publication Number Publication Date
ATE252600T1 true ATE252600T1 (de) 2003-11-15

Family

ID=27157841

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96902810T ATE252600T1 (de) 1995-03-02 1996-02-22 Ein neuartiger wachstumfaktor und eine genetische sequenz die für diesen kodiert

Country Status (16)

Country Link
US (1) US20070135344A1 (de)
EP (1) EP0815221B1 (de)
JP (2) JPH11500139A (de)
KR (1) KR100414615B1 (de)
CN (1) CN1194090C (de)
AT (1) ATE252600T1 (de)
BR (1) BR9607628A (de)
CA (1) CA2214439C (de)
DE (1) DE69630442T2 (de)
ES (1) ES2206558T3 (de)
FI (1) FI120153B (de)
HK (1) HK1002963A1 (de)
HU (1) HU223438B1 (de)
NO (1) NO320839B1 (de)
NZ (2) NZ301611A (de)
WO (1) WO1996027007A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928939A (en) * 1995-03-01 1999-07-27 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b and dna coding therefor
CA2224002A1 (en) * 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Human vascular endothelial growth factor 3
EP0848755B2 (de) 1995-09-08 2011-02-09 Genentech, Inc. Vegf-verwandtes protein
ATE459715T1 (de) 1995-09-29 2010-03-15 Univ Siena Regulierte gene und ihre verwendungen
US6994989B1 (en) 1995-11-08 2006-02-07 Immunex Corp. FLK-1 binding proteins
AU1116297A (en) 1995-11-08 1997-05-29 Immunex Corporation Flk-1 binding protein
ES2251740T3 (es) 1996-08-23 2006-05-01 Ludwig Institute For Cancer Research Factor de crecimiento de celulas de endotelio vascular d recombinante (vegf-d).
CN1680442A (zh) * 1997-04-25 2005-10-12 科莱特诺医疗公司 截短的vegf相关蛋白质
NZ505955A (en) 1998-02-06 2005-04-29 Collateral Therapeutics Inc Variants of the angiogenic factor vascular endothelial cell growth factor: VEGF-A, and pharmaceutical use
US7105481B2 (en) 1998-11-10 2006-09-12 Ludwig Institute For Cancer Research Method for stimulating connective tissue growth or wound healing
CA2349951A1 (en) 1998-11-10 2000-05-18 Ludwig Institute For Cancer Research Platelet-derived growth factor d, dna coding therefor, and uses thereof
JP4739526B2 (ja) 1998-12-07 2011-08-03 ザイモジェネティクス， インコーポレイテッド 成長因子相同体ｚｖｅｇｆ３
US6783953B1 (en) 1998-12-22 2004-08-31 Janssen Pharmaceutica N.V. Vascular endothelial growth factor-X
AUPQ568100A0 (en) * 2000-02-16 2000-03-09 Amrad Operations Pty. Limited A method for producing recombinant molecules
US7026462B2 (en) 2000-12-07 2006-04-11 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7067317B2 (en) 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7981863B2 (en) * 2001-09-19 2011-07-19 Neuronova Ab Treatment of Parkinson's disease with PDGF
CA2599004C (en) 2005-02-28 2015-05-26 Sangamo Biosciences, Inc. Anti-angiogenic methods and compositions
CN100448892C (zh) * 2006-08-02 2009-01-07 中国人民解放军军事医学科学院基础医学研究所 抗肿瘤血管内皮生长因子受体vegf－r2抗原及其编码基因与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073492A (en) * 1987-01-09 1991-12-17 The Johns Hopkins University Synergistic composition for endothelial cell growth
US5332671A (en) * 1989-05-12 1994-07-26 Genetech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5219739A (en) * 1989-07-27 1993-06-15 Scios Nova Inc. DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF120 and hVEGF121
US5338671A (en) * 1992-10-07 1994-08-16 Eastman Kodak Company DNA amplification with thermostable DNA polymerase and polymerase inhibiting antibody
DE69434538T2 (de) * 1994-03-08 2006-08-10 Human Genome Sciences, Inc. Vaskulärer endothelialer Wachstumsfaktor 2
US5607918A (en) * 1995-03-01 1997-03-04 Ludwig Institute For Cancer Research Vascular endothelial growth factor-B and DNA coding therefor
US5928939A (en) * 1995-03-01 1999-07-27 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b and dna coding therefor

Also Published As

Publication number Publication date
NZ337634A (en) 2001-06-29
HUP9800377A3 (en) 2000-12-28
NO974035D0 (no) 1997-09-02
NZ301611A (en) 2000-02-28
CA2214439A1 (en) 1996-09-06
US20070135344A1 (en) 2007-06-14
HUP9800377A1 (hu) 1998-06-29
CA2214439C (en) 2002-12-17
HK1002963A1 (en) 1998-09-30
KR100414615B1 (ko) 2004-05-27
DE69630442D1 (de) 2003-11-27
BR9607628A (pt) 1999-11-30
EP0815221A4 (de) 1998-12-09
EP0815221B1 (de) 2003-10-22
NO320839B1 (no) 2006-01-30
FI120153B (fi) 2009-07-15
KR19980702702A (ko) 1998-08-05
JP2001037493A (ja) 2001-02-13
JPH11500139A (ja) 1999-01-06
ES2206558T3 (es) 2004-05-16
FI973571A0 (fi) 1997-09-01
FI973571A (fi) 1997-10-30
CN1224464A (zh) 1999-07-28
NO974035L (no) 1997-11-03
DE69630442T2 (de) 2004-08-19
HU223438B1 (hu) 2004-07-28
CN1194090C (zh) 2005-03-23
WO1996027007A1 (en) 1996-09-06
JP3683778B2 (ja) 2005-08-17
EP0815221A1 (de) 1998-01-07

Similar Documents

Publication Publication Date Title
ATE252600T1 (de) Ein neuartiger wachstumfaktor und eine genetische sequenz die für diesen kodiert
DE69021263D1 (de) Fibronektinbindungsprotein und dessen Herstellung.
DK0939767T3 (da) Procin faktor VIII og hybrider deraf
DE69327645T2 (de) Dna-sequenzen kodierend für neuartige wachstums-/differentierungsfaktoren
ATE189475T1 (de) Wachstums-differenzierungsfaktor der tgf-b familie
DE69533564D1 (de) Effektor-Proteine für Rapamycin
ATE196164T1 (de) Gereinigte scytalidium lacassen und nukleinsäuren dafür kodierend
DE69841105D1 (de) Chemokine peptide, varianten, derivate und analoge. ihre verwendung in methode für die hemmung oder erhöhung von einer entzündungsreaktion
SI1346034T1 (sl) POLIPEPTID PROTEAZE, KI CEPI VON WILLEBRANDOV FAKTOR (vWF), NUKLEINSKA KISLINA, KI KODIRA POLIPEPTID, IN UPORABA POLIPEPTIDA
DE69636495D1 (de) Multi-tumor abweichende wachstumsgene
ATE394484T1 (de) Smad 6 und dessen anwendungen
DE69328025D1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
ATE253113T1 (de) Für ein fibroblasten-aktivierungsprotein kodierende nukleinsäure und verwendungen dafür
DE3853446D1 (de) Fibronectinbindungsprotein und dessen Herstellung.
FI930626A (fi) Proteinstruktur hos vaexttoxingelonin
DE69120390T2 (de) Kollagen-bindendes protein sowie dessen herstellung
ATA169294A (de) Formteil zur herstellung von trägerkörpern für katalysatoren, kondensatorkörpern, filter od. dgl.
PT714441E (pt) Alergenios recombinantes de cladosporium herbarum
DE69838459D1 (de) Für den licht-überempfinlichkeitsphaenotyp kodierende nukleotidsequenzen von tomaten, dadurch kodierte proteine und deren verwendungen
ATE338126T1 (de) Dna-sequenz und rekombinante herstellung eines graminaen-allergens
DE60039708D1 (de) Menschliches chordin und polynukleotiden die dafür kodieren
IT1256078B (it) Ligandi kit solubili
ITMI921476A1 (it) Sequenze nucleotidiche codificanti proteine vegetali inattivanti i ribosomi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0815221

Country of ref document: EP